Transdifferentiation is the name used to describe the direct conversion of one differentiated cell type into another. Cells which have the potential to interconvert by transdifferentiation generally arise from adjacent regions in the developing embryo. For example, the liver and pancreas arise from the same region of the endoderm. The transdifferentiation of pancreas to liver (and vice versa) has been observed in animal experiments and in certain human pathologies. Understanding transdifferentiation is important to developmental biologists because it will help elucidate the cellular and molecular differences that distinguish neighbouring regions of the embryo. While the in vivo models for the transdifferentiation of liver to pancreas have been valuable, it is more difficult to extrapolate from these studies to individual changes at the cellular or molecular levels. The recent development of two in vitro systems (AR42J cells and embryonic pancreatic cultures) for the transdifferentiation of pancreas to liver has shown that an environmental change in the form of an exogenous glucocorticoid can cause the conversion of pancreatic exocrine cells into hepatocytes. The AR42J cell system has been used to elucidate the cell lineage and the molecular basis of transdifferentiation of pancreas to liver. q
1. Introduction
Examples of transdifferentiation and theoretical considerations
Transdifferentiation is the name used to describe the conversion of one differentiated cell type to another (Slack and Tosh, 2001; Tosh and Slack, 2002) . It is a subset of a wider class of cell type interconversions called metaplasias, which also includes interconversions between stem cells (Slack, 1986) . These phenomena are important for a number of reasons. Firstly, understanding the molecular basis of the conversions will extend our knowledge of the normal developmental mechanism (see below). Secondly, some types of transdifferentiations predispose to neoplasia and are important in human pathology. Thirdly, understanding the molecular rules for cell or tissue-type conversions will improve our ability to reprogramme stem cells for the purpose of therapeutic transplantation.
The term 'transdifferentiation' was first introduced by Selman and Kafatos to describe a switch in cell differentiation when they observed a change in the state of the cuticleproducing cells to salt-secreting cells in the silkmoth during metamorphosis from the larval to the adult moth (Selman and Kafatos, 1974) . Okada and Eguchi identified the switch of epithelial pigment cells to lens cells during regeneration as 'transdifferentiation' , and convincingly demonstrated the switch through an in vitro clonal cell culture system (Eguchi and Okada, 1973; Araki and Okada, 1977; Okada 1991) . Another naturally occurring transdifferentation also occurs in the mammalian oesophagus where there is a switch from smooth to skeletal muscle during embryogenesis (Patapoutian et al., 1995) . Eguchi defined transdifferentiation as an irreversible switch of one type of differentiated cell to another (Eguchi, 1995) . In order for a switch in phenotype to be considered as a true transdifferentiation, they considered that two important criteria must be established: (1) The differentiated states before and after the conversion must be clearly defined. This normally requires both morphological and molecular and/or biochemical characterization; (2) The cell lineage relationship between the two cell types needs to be clearly established. This nearly always requires some form of lineage labelling, although it can sometimes be established by direct observation in tissue culture. Cell division often accompanies transdifferentiation, but there are examples where it does not do so (Beresford, 1990) .
Another term which is commonly used to describe a switch in cell or tissue type is 'metaplasia'. This term has long been used in human pathology to describe the unexpected appearance of foreign tissues in ectopic sites (Slack 1986) . It is nearly always found in association with tissue damage and regeneration. Presumably this occurs because regeneration facilitiates changes in the expression of key transcription factors that lead to an alteration in the state of developmental commitment of a cell. The changes can be brought about by somatic mutation or environmental changes. Metaplasias of epithelia are common and in fact often consist of the conversion of one patch of tissue into another type that arose as an adjacent rudiment in the embryo (Slack 1986 (Slack , 2000 . For example, patches of ectopic intestinal epithelium are found in the stomach (Matsukura et al., 1980) and colonic type epithelium is found in the urinary bladder (Ward 1971) . Recently, we have used 'metaplasia' to refer to any switch of cell type regardless of pathway, and 'transdifferentiation' to refer to direct transformations of one differentiated cell type to another, with or without cell division (Slack and Tosh, 2001; Tosh and Slack, 2002) . According to these definitions, the examples to be described in this review fall under the heading of 'transdifferentiation'.
What can transdifferentiation tell us about embryonic development?
During embryogenesis, tissues that develop as neighbouring rudiments in a common cell sheet will have similar combinations of transcription factors defining their commitment. Neighbouring tissues may differ by the expression of just one or a few transcription factors (Slack and Tosh, 2001; Tosh and Slack, 2002) . A previous theoretical work suggested that metaplasias might result from somatic mutation of homeotic genes normally required to distinguish tissue rudiments from one another (Slack 1985) . Assuming that stem cells in the adult are the same as the original embryonic progenitors for the tissue, a change of state of such a gene(s) in later life would cause the stem cells to produce another tissue type (Fig. 1) . Since metaplasia represents a switch in developmental commitment of one tissue type to another, investigating the phenomenon provides a Fig. 1 . Mechanism of transdifferentiation in postnatal life. In the embryo, two tissue types arise from a common cell sheet because the master switch gene, X, is activated through induction by a morphogen. The region expressing gene X becomes tisue B. In postnatal life, either a change in the cellular environment or somatic mutation turns gene X on in one or a few cells of the B tissue, then a metaplasia results. The figure was modified from Slack (2000) ; Tosh and Slack (2002) . novel opportunity to explore the cellular and molecular mechanisms that may underlie specification of different organs during development. Transdifferentiation events always differ from the normal sequence of development by definition. However, an understanding of transdifferentiation events may also help to understand normal development. One example where this has proved informative is that of the homeobox gene Cdx2, a homologue of the Drosophila gene caudal. Cdx2 was implicated in the control of cell differentiation in the intestinal epithelium. Recently, it has been shown that inactivation of one allele of Cdx2 in mice caused the formation of foci of heterotopic stomach and small intestinal mucosa in the colon suggesting that Cdx2 directs endodermal differentiation towards a colonic phenotype (Beck et al., 1999 ).
Transdifferentiation of the pancreas to liver in vivo
The appearance of hepatic foci in the pancreas occurs in rats, hamsters, mice, monkeys and humans in different experimental conditions (for a summary of the various treatments and pathologies see Table 1 ).
One of the first experiments to describe the potential for transdifferentiation in the pancreas was performed by Scarpelli and Rao (1981) . While using a methionine-deficient protocol to induce regeneration of pancreas in Syrian golden hamster, they observed hepatocytes, as judged by the presence of albumin, peroxisomes, and a variety of morphological features, in the regenerating pancreas. The authors suggested that the conversion had been triggered by a single dose of the carcinogen N-nitrosobis (2-oxopropyl) amine administered during the S phase in regenerating pancreatic cells. These results indicate that, given the correct stimulus, regenerating cells in the adult pancreas can be redirected down a completely different pathway of differentiation to become hepatocytes. Since then diverse protocols have been used to induce hepatocytes in the pancreas such as treatment with peroxisome proliferators (e.g. ciprofibrate) (Rao et al., 1982; Reddy et al., 1984) or certain carcinogens (Rao et al., 1988b; Monis et al., 1991; Waalkes et al., 1992) , transplantation of epithelial cells (Dabeva et al., 1997) or overexpression of keratinocyte growth factor (KGF, also known as fibroblast growth factor (FGF)-7) in pancreatic islets (Krakowski et al., 1999) . It has also been observed naturally in the vervet monkey (Wolfe-Coote et al., 1996) and in human pancreatic tumours (Paner 2000) . Although these whole organism observations cannot prove definitively that the hepatocytes were derived from pancreatic cells (they could theoretically have migrated from the liver), they do suggest the likelihood of a high frequency of conversion between pancreatic cells and hepatocytes.
Perhaps the most extensively studied in vivo model of the hepatic metaplasia of pancreas is the copper depletionrepletion protocol (Rao et al., 1986b; Rao et al., 1988a; Dabeva et al., 1995) . This is highly reproducible in vivo model, in which hepatocytes are induced in the pancreas of adult rats maintained on copper-deficient diet containing a copper-chelating agent, Trien, for 7-9 weeks and then returned to normal rat chow. This protocol results in almost a complete loss of pancreatic acinar cells at the end of copper-depletion phase, and in the development of multiple foci of hepatocytes during the recovery phase. In some animals, the liver cells occupied more than 60% of pancreatic volume within 6-8 weeks of recovery (Rao et al., 1988a) .
Although the in vivo models for the transdifferentiation of liver to pancreas have been extremely valuable and demonstrate the potential for pancreas to liver transdifferentiation, it is more difficult to determine the molecular or cellular mechanisms from these studies.
Hepatic transdifferentiation of the pancreas in vitro
Despite the investigation of this phenomenon for over 20 years, the mechanism responsible for transdifferentiation remained unclear. The main reason is that it is difficult to extrapolate from in vivo studies to individual changes at the cellular or molecular level. One approach to proving that pancreatic hepatocytes arise directly from pancreatic cells is to establish in vitro model systems by using differentiated pancreatic cells. If it proves possible to induce transdifferentiation of pancreatic cells to liver then it may be very useful for determining the mechanisms involved.
One such pancreatic cell line available is called AR42J. AR42J cells are a cell line originally isolated from a carcinoma of an azaserine-treated rat (Longnecker et al., 1979; Christophe 1994 ). These cells are amphicrine i.e. they possess both exocrine and neuroendocrine properties. Under normal circumstances, AR42J cells exhibit an exocrine phenotype (i.e. they express the pancreatic digestive enzyme amylase). The expression of amylase can be enhanced by short-term (48 h) culture with the synthetic glucocorticoid, dexamethasone (Logsdon et al., 1985) . AR42J cells can also be induced to produce insulin-secreting b-cells by culture with activin and HGF or betacellulin (Mashima et al., 1996a,b) . The addition of glucagon-like peptide-1 (GLP-1) to AR42J cells produces insulin and glucagon-producing cells (Zhou et al., 1999) . A subclone of the parent cell line (called AR42J-B13 or simply B13) has been isolated (Mashima et al., 1996b) , which has a greater disposition to convert to the endocrine phenotype following culture with activin and HGF. The ability of the AR42J cell line to produce a variety of differentiated pancreatic cell types makes it a model for pancreatic stem cells and a potentially interesting system to study transdifferentiation to liver. We have demonstrated the ability of dexamethasone to also induce the formation of hepatocytes from AR42J-B13 or the parent AR42J cells (Shen et al., 2000) . The hepatocytes produced exhibit many of the properties of true hepatocytes expressing a range of markers including albumin, glucose-6-phosphatase, transferrin and transthyretin.
Origin of pancreatic hepatocytes
The pancreas is an organ containing both exocrine and endocrine tissues. The exocrine tissue is composed of the acinar cells secreting the digestive enzymes (e.g. amylase, lipase, elastase) together with the epithelial cells of the pancreatic ducts that transport the digestive enzymes from the pancreas to the small intestine. The ducts may be the sites of residence of pancreatic stem cells responsible for renewing the tissue (Ramiya et al., 2000) . The endocrine tissue is mostly organised in the islets of Langerhans that are composed of different cell types depending on the hormone that they secrete (a cells: glucagon, b cells: insulin, g cells: somatostatin, PP cells: pancreatic polypeptide). The question that arises is in which cell type do hepatocytes originate? The in vivo model systems have suggested several different answers to this question.
The first model which suggests that the exocrine or endocrine cell is the cell of origin for pancreatic hepatocytes is based on administration of ciprofibrate to rats. Reddy and co-workers used ciprofibrate to induce hepatocytes in the pancreas of adult male F-344 rats when supplemented in their diet (Reddy et al., 1984) . These hepatocytes were usually localized both adjacent to islets of Langerhans and extended into the surrounding acinar tissue. Uricasecontaining crystalloid nucleoids, which are specific for rat hepatocyte peroxisomes, were present and used to identify the hepatocytes. The presence of exocrine zymogen granules or endocrine secretory granules in the cells with uricase crystalloid nucleoids suggests that there is a transitional state in which pancreas-specific genes are being repressed while liver-specific ones are induced and upregulated. The result indicates that either acinar or endocrine cells could represent the precursor cell type from which pancreatic hepatocytes are derived.
The second model suggesting that the pancreatic ductular epithelium is the cell of origin for hepatocytes is the copper depletion-repletion model. During the depletion period, there was an increase in the number of adipocytes in the interstitium, and in the number of interstitial and ductular cells. After 7 weeks of copper deficiency, albumin mRNA is localized over interstitial and ductular cells. These cells resemble morphologically the epithelial progenitors of the liver, the oval cells that are normally resident in the hepatic biliary system (Rao et al., 1989; Dabeva et al., 1995) . Transplantation of these cells into liver can bring about full differentiation into hepatocytes (Dabeva et al., 1997) suggesting that there were hepatic progenitors in these interstitial and ductular cells.
The third model is based on transgenic mice in which KGF (FGF7) was overexpressed in the pancreas under the control of the rat insulin promoter (Krakowski et al., 1999) . Hepatocytes were present within the islets of Langerhans. Additionally, significant intra-islet duct cell proliferation in the pancreas of transgenic KGF mice was observed. The unexpected appearance of hepatocytes and proliferation of intra-islet duct cells in the pancreas of these mice suggest that endocrine cells may have the potential upon local exposure to KGF to transdifferentiate to hepatocytes either directly or indirectly through an intermediate ductal cell stage.
These three studies, therefore, suggest a different cellular origin for the pancreatic hepatocytes: acinar, endocrine or ductular. The possibility exists that all three cell types do have the potential to transdifferentiate to hepatocytes. However, it is difficult to establish the cell lineage relationship conclusively from the whole-animal experiments because no labelling of individual cell lineages was carried out. In order to determine the origin of pancreatic hepatocytes, we used the pancreatic AR42J-B13 cells to establish the cell lineage experiment based on perdurance (stability) of GFP protein (Shen et al., 2000; Corish and Tyler-Smith, 1999) .
Due to the nature of the B13 cells, it is possible that hepatocytes could arise from exocrine or undifferentiated (putative stem) cells. Under normal culture conditions, there are no differentiated endocrine cells present. To distinguish exocrine from undifferentiated cells, we used the 200 bp fragment of the elastase promoter to drive GFP (Swift et al., 1989) . B13 cells were transfected with the construct and photographed on successive days following treatment with dexamethasone (Fig. 2) . This showed that, although the elastase promoter is rapidly turned off, the GFP can persist in hepatocytes expressing the liver marker, glucose-6-phosphatase. This result does not prove that all hepatocytes originate from the same cell type, but it does indicate that at least some of the hepatocytes are formed directly from cells with an active elastase promoter. This result compares favourably with the observations from animal models that suggest that hepatocytes might be derived from exocrine cells (Reddy et al., 1984) .
Additional support for the exocrine-hepatocyte transdifferentiation is provided from the observations of the reverse conversion of hepatocyte to pancreas: (1) exocrine pancreatic tissue can be induced by administration of the carcinogen polychlorinated biphenyl in the liver of rats (Rao et al., 1986a) ; (2) exocrine pancreatic tissue in the liver of a 41-year-old patient with posthepatitic cirrhosis (Wolf et al., 1990) ; and (3) exocrine enzymes (trypsinogen, lipase and amylase) are also expressed in liver during human liver development (Terada and Nakanuma, 1995) . These examples presumably reflect the close relationship between pancreatic exocrine cells and hepatocytes.
The treatment of mouse embryonic pancreatic buds with glucocorticoid also induces transdifferentiation to hepatocytes (Shen et al., 2000) demonstrating that this effect is not simply a tissue culture artifact, but mimics a normal developmental switch. The co-localisation of amylase and albumin in some cells also supports the conclusion from the GFP perdurance experiment on the B13 cell line that at least some of the hepatocytes arise by direct transdifferentiation from pancreatic exocrine cells. The hepatic transdifferentiation in B13 cells is basically a unidirectional process, and fulfils the criteria of the transdifferentiation: (1) The differentiated states before and after the transdifferentiation can be clearly defined by losing pancreatic phenotype and expression of hepatic marker genes. (2) The cell lineage relationship between the two cell types is established.
Molecular basis of hepatic transdifferentiation of pancreas
Hepatic transdifferentiation of the pancreas has been studied for over 20 years, but only two studies (Rao et al., 1996; Dabeva et al., 1995) have investigated the genes that are involved in transdifferentiation. The results showed that HNF-1, HNF-3a, HNF-3b, HNF-4, C/EBPa C/EBPb and C/EBPg were expressed in the pancreas of copper-depletion rats (Dabeva et al., 1995; Rao et al., 1996) . The authors suggested that the liver-enriched transcription factors (LETFs) might be involved in the mechanism underlying the process of transdifferentiation. Several of these transcription factors are, however, also present in the normal pancreas (Cereghini, 1996) . For example, both HNF-4 and HNF-1 are normally expressed in the islet of Langerhans (Miquerol et al., 1994) , and HNF-1 is essential for insulin gene transcription (Emens et al., 1992; Wang et al., 1998) . It seems unlikely that factors normally present in both tissues would be the cause of transdifferentiation, although this does not exclude the possibility that transcription factors common to both pancreas and liver participate in the conversion. It is more likely that if the two tissues differ in the expression of one or two transcription factors then these are prime candidates for the master switch genes i.e. it is the overall combination of transcription factors that are important.
In order to determine the molecular mechanism involved in the transdifferentiation of pancreas to liver we investigated the molecular events associated with the hepatic transformation by using AR42J-B13 cells (Shen et al., 2000) . Our attention was initially drawn to the molecules commonly regarded as liver-enriched transcription factors, namely HNF1, HNF3b, HNF3g, HNF4a and HNF6. All these are normally expressed in the pancreas as well as the liver as mentioned previously; they are also expressed in AR42J-B13 cells (Fig. 3A) , but the mRNA levels do not increase significantly on Dex treatment. On the other hand, the C/EBPb is not normally expressed in pancreas (Tronche and Yaniv 1992; Cereghini, 1996) . Shortly after B13 cells are exposed to glucocorticoid, we found that C/EBPb was expressed in the cells that were associated with the suppression of the pancreatic phenotype, nuclear translocation of HNF-4a and activation of differentiated hepatic products (Fig. 3B, C) . This observation makes C/EBPb a good candidate for switching the pancreatic phenotype to liver. More importantly, transfection of C/EBPb into the cells can itself provoke the transdifferentiation (Fig. 3D, E) , while LIP (liver inhibitory protein), the dominant-negative form of C/EBPb (Descombes and Schibler, 1991) can inhibit the process. These results suggest that C/EBPb is a key component distinguishing between the liver and pancreatic programs of differentiation.
Essential role of C/EBP in hepatic transdifferentiation
C/EBPa, b and g mRNAs have been shown to increase during regeneration of the copper-deprived pancreas, at about 4-5 weeks, just before the appearance of visible hepatocytes. However, in the copper deprivation regime, the exocrine pancreas mainly degenerates and is replaced by fibrous tissue. When the animals are re-fed on a normal diet, there is a rapid accumulation of fat in this interstitial tissue. The exocrine acini then regenerate over several weeks from small foci, and are accompanied by the growth of foci of hepatocytes. Since C/EBPb is known to be involved in adipogenesis (Tanaka et al., 1997; Darlington et al., 1998) , its presence in the regenerating pancreas may simply be associated with the fatty transformation of the (B, C) AR42J-B13 cells were incubated without or with Dex 1 OSM for 5 days and stained for (B) C/EBPb (red) and Glucose-6-phosphatase (green); (C) HNF-4a (green) and C/EBPb (red); Although HNF4 is present in the parent cells, it has migrated into the nucleus in all cells expressing C/EBPb; hence, the orange nuclei. (D, E) AR42J-B13 cells were transfected with pcDNA3-C/EBPb. After 4 days of transfection, it was then immunostained with anti-C/EBPb (red) and anti-G6Pase (green). The cell that received C/EBPb became a hepatocyte, as indicated by the flattened appearance and expression of G6Pase. fibrous tissue rather than the transdifferentiation of exocrine cells.
In normal development, in vivo footprinting shows that C/EBPb is actually bound to the albumin gene enhancer of embryonic hepatocytes (Bossard et al., 1997) , indicating a role of C/EBPb in early liver development. Evidence from mouse knockouts has so far not shown a major function for C/EBPs, although C/EBPb has been shown to act as a key regulator of liver regeneration (Diehl 1998) . However, the knockouts of C/EBPa and C/EBPb do have slight liver defects (Wang et al., 1995; Screpanti et al., 1995; Liu et al., 1999) . It remains possible that simultaneous knockouts of all C/EBP-type genes may cause a major liver defect and it is significant that the deletion of the C/EBP homologue in Drosophila is embryonically lethal (Rørth and Montell, 1992) .
Importance of HNF-4 in hepatic transdifferentiation
HNF-4 may also play a role in transdifferentiation as it migrates to the nuclei at an early stage in the process. HNF-4 is a member of the nuclear receptor superfamily (Sladek et al., 1990) . These factors normally exist in the cytoplasm, and the ligand-induced translocation to the nucleus is an important step in regulating their target activity. HNF-4 is abundant in adult and fetal livers and intestines. Low-level expression of HNF-4 can also be found in pancreatic islets of Langerhans, while it is scarcely detectable in the exocrine pancreas (Miquerol et al., 1994) . HNF-4 is known to play a critical role in regulating the function of normal pancreatic b-cell, because a mutation in this factor causes maturity onset diabetes of the young type 1 (MODY1) (Yamagata et al., 1996) .
The importance of HNF-4 in liver differentiation comes from several studies looking at the role of HNF-4 in both early development and regeneration. In the developing mouse, HNF-4 is normally expressed in the early visceral endoderm, an extraembryonic tissue that shares many biochemical features with the liver. Disruption of the HNF-4 gene in visceral endoderm blocks the expression of a-fetoprotein, apolipoprotein, transthyretin and transferrin (Duncan et al., 1997) , and the mice die early due to the failure of the visceral endoderm. Recent studies, however, have shown that in HNF-4-/-fetal livers a large number of genes, which are essential for hepatic function, are not expressed (Li et al., 2000 , Hayhurst et al., 2001 . HNF-4 has also been shown to play a critical role in liver regeneration (Nagy et al., 1994) . If rats are treated with aminoacetylfluorene to inhibit hepatocyte growth, and then subjected to partial hepatectomy, liver regeneration proceeds from oval cells associated with the bile ducts (Alison, 1998) . During this process, the expression of HNF-4 is first observed when the oval cells differentiate morphologically and functionally into hepatocytes (Nagy et al., 1994) . Lastly, it has been shown that HNF-4 plays an important role in maintaining the differentiated phenotype of hepatocytes. HNF-4 expression in dedifferentiated hepatoma cells overcomes the repression of the hepatic phenotype (Spath and Weiss, 1997; 1998) . These results imply that HNF-4 plays a critical role in regulating liver differentiation, both in development and in regeneration.
Conversion of liver to pancreas
The pancreas and liver arise from adjacent areas in the anterior endoderm of the developing embryo (Wells and Melton, 1999) . It suggests that the developmental commitment of liver and pancreas differs by the expression of only a few genes and it might also be possible to induce the reverse transdifferentiation and convert liver into pancreas. In fact, pancreatic-type exocrine tissue has been found to occur in the livers of rats treated with polychlorinated biphenyls (Rao et al., 1986a) , in fish-liver tumors induced by chemical carcinogens (Lee et al., 1989) , or in the liver of a human patient with hepatic cirrhosis (Wolf et al., 1990) . There is currently no evidence to show that liver can be induced to transdifferentiate to pancreatic endocrine cells.
Pdx-1 is one of the strongest candidates for transdifferentiating liver to pancreas. It is a homeodomain protein (Habener and Hussain, 2001 ) expressed in the developing pancreatic anlagen that is first expressed when the foregut endoderm is being committed to a pancreatic fate. In Pdx1-/-mice, pancreatic tissue is missing (Jonsson et al., 1994; Offield et al., 1996) . The mutant pups survive fetal development but die within a few days after birth. Although a few glucagon and insulin positive cells are detected early, no pancreatic tissue is detected in mutant embryos and neonates. These findings show that Pdx-1 is needed for the formation of the entire pancreas and suggest that it acts to determine the fate of common pancreatic precursor cells and/or to regulate their propagation. In contrast, in the adult mouse pancreas, Pdx-1 is selectively expressed in the b-cells and binds and transactivates the insulin promoter (Habener and Hussain, 2001) . In this context, Pdx-1 plays an important role in maintaining the b-cell phenotype as specific inactivation of the mouse pdx1 gene in b-cells results in the loss of insulin-producing cells followed by development of Type II (maturity onset) diabetes (Ahlgren et al., 1998) . In combination, these results demonstrate the importance of Pdx-1 in both initial pancreas development and in maintaining the b-cell phenotype.
The essential role played by Pdx-1 in pancreas development has led three groups to overexpress it in various regions within the gastrointestinal tract (Ferber et al., 2000; Grapin-Botton et al., 2001; Heller et al., 1998) . Although each group has obtained some phenotypic change, there is no evidence of ectopic pancreatic differentiation. In the study of Ferber et al. (2000) , recombinant adenovirusmediated gene transfer of Pdx-1 to the livers of BALB/C and C57BL/6 mice activated expression of the endogenous, otherwise silent, genes for mouse insulin 1 and 2 and prohormone convertase 1/3 (PC 1/3) in a small proportion of infected cells. Expression of Pdx-1 resulted in a substantial increase in hepatic and plasma immunoreactive insulin content as compared with that in mice treated with control adenovirus. The ectopic insulin produced in the liver was biologically active, as it ameliorated hyperglycemia in diabetic mice treated with streptozotocin. As only a small proportion of infected cells produced any insulin, this raises the question of whether Pdx-1 can bring about transdifferentiation of hepatocytes to pancreatic b cells or whether it simply activates the insulin gene in liver cells. Nevertheless, the results do suggest that given the right environment, Pdx-1, or another pancreatic transcription factor, may be able to transdifferentiate liver to pancreas.
Questions for the future
From the observation of our in vitro models, we suggest that C/EBPb plays an important role in hepatic transdifferentiation of the pancreas. C/EBPb is not normally expressed in pancreas. We believe that, in postnatal life, either a change in the cellular environment or somatic mutation turns the pancreatic transcription factors off and the C/EBPb on in one or a few cells of the pancreas, which may lead to the hepatic transdifferentiation. Although some of the details of the transdifferentiation of pancreas to liver have now been established, some questions still remain to be answered. In particular, the role of C/EBPb (and other members of the C/EBP family) in normal liver development is poorly understood.
Hepatocytes differentiate from the endoderm during embryonic development. FGF signalling from the cardiac mesoderm and BMP signalling from the septum transversum mesenchyme is necessary to induce liver genes in the endoderm (Jung et al., 1999; Rossi et al., 2001; Zaret, 2001) . Although FGF signalling has been shown to divert the ventral pancreas to express genes for liver (Deutsch et al., 2001) , it remains to be seen whether FGFs and BMP are involved in hepatic transdifferentiation. The in vitro models suggest the possibility that endogenous glucocorticoids may be involved in the normal developmental decisions that operate to subdivide the foregut endoderm into stomach, pancreas, liver and intestine. Glucocorticoid has a variety of effects on hepatocytes including the ability to induce the synthesis of albumin, transferrin, tyrosine aminotransferase, and glucose-6-phosphatase (Chou et al., 1988; Schmoll et al., 1996; Kamiya et al., 1999) . In fact, glucocorticoid in combination with oncostatin M (a member of the IL-6 family) is known to accelerate the maturation process in fetal murine hepatocytes Kinoshita et al., 1999) . As these factors have not previously been considered to be embryonically inducing factors, a possible endogenous role for glucocorticoids and in regional specification of the foregut needs to be further investigated.
Previous studies have suggested that hepatic precursor cells reside within or close to pancreatic ducts (Dabeva et al., 1995; Dabeva et al., 1997) . Therefore, it is also necessary to determine whether hepatocytes can arise from other pancreatic cell types apart from exocrine cells and whether the transdifferentiation of exocrine cells to hepatocytes has any real significance to the situation in humans. In order to determine whether adult pancreas contains cells that can give rise to therapeutically useful and biochemically normal hepatocytes, mouse pancreatic cells have been transplanted into syngeneic recipients deficient in fumarylacetoacetate hydrolase and manifesting tyrosinemia (Wang et al., 2001) . Some of the mutant mice were fully rescued by donor-derived cells and had normal liver function. More than one-third of mutant mice showed histological evidence of donor-derived hepatocytes. However, additional transplantations using either primary cell suspensions enriched for ducts or cultured ducts showed no donor-derived hepatocytes. These results are consistent with the idea that it is either the pancreatic exocrine cells or the periductular cells that form hepatocytes by direct transdifferentiation. Recent evidences also show that tissue-specific stem cells can give rise to cells of heterologous lineages (Goodell, 2001) . For example, hepatocytes can differentiate from hematopoietic stem cell populations. Recent lineage-marking studies of mice after bone-marrow transplantation have challenged the view that hepatocytes must be derived from the endoderm or endoderm-derived cells (Petersen et al., 1999; Alison et al., 2000; Lagasse et al., 2000) . Although the interpretation of these experiments require re-examination in the light of other recent experiments (Ying et al., 2002; Terada et al., 2002) , it remains important to establish whether there exists a common stem cell for liver and pancreas, and whether there are pathways of transdifferentiation in addition to that established so far.
